Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008
Operating Activities
Net Income $89.8M $65.3M
Depreciation & Amortization $28.6M $30.4M
Depreciation $21.8K —
Amortization $6.8M —
Stock-Based Compensation $10.0M $7.3M
Net Cash from Operating Activities $133.9M $103.3M
Investing Activities
Capital Expenditures $20.2M $16.0M
Business Acquisitions $0 —
Net Cash from Investing Activities $-20.2M $-10.8M
Financing Activities
Dividends Paid $29.0M $27.9M
Stock Repurchases $21.1M $6.1M
Net Cash from Financing Activities $-73.0M $-62.7M
Net Change in Cash $43.5M $27.3M
Free Cash Flow $113.7M $87.3M
← Newer Page 3 of 3 Older →